Amy Rochford
Founder
Axo
Axo develops advanced neural interfaces using a biology-first engineering approach. This creates more intuitive and integrated connections between biological neural pathways and digital systems, advancing human-computer interaction and neural engineering applications.
Updated 5 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Nathan Jackrazi
Founder
Product
Problem
Current neural interface technologies often struggle to achieve a truly seamless and natural integration with biological systems. This limitation hinders the development of advanced human-computer interaction and the full potential of neural engineering applications.
Solution
Axo is developing next-generation neural interfaces by adopting a biology-first engineering approach. This methodology focuses on creating a more intuitive and integrated connection between biological neural pathways and digital systems. By prioritizing biological compatibility and function, Axo aims to advance the capabilities of neural interfaces for a range of applications. The company's work is positioned at the forefront of neural engineering, seeking to unlock new possibilities for human-technology interaction.
Target Audience
The primary target audience includes researchers and developers in the fields of neuroscience, bioengineering, and human-computer interaction.
Features
- Biology-first design philosophy for enhanced neural integration.
- Focus on developing advanced neural interface hardware and software.
- Engineering approach that prioritizes natural biological interaction.